Valuation: Danaher Corporation

Capitalization 160B 137B 129B 120B 222B 14,383B 241B 1,505B 581B 6,793B 600B 587B 24,837B P/E ratio 2025 *
43.5x
P/E ratio 2026 * 32.8x
Enterprise value 173B 149B 139B 130B 240B 15,565B 261B 1,629B 629B 7,351B 649B 635B 26,879B EV / Sales 2025 *
7.06x
EV / Sales 2026 * 6.66x
Free-Float
72.69%
Yield 2025 *
0.55%
Yield 2026 * 0.6%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.39%
1 week-0.23%
Current month-0.23%
1 month+7.40%
3 months+13.01%
6 months+15.42%
Current year-1.44%
More quotes
1 week 223.75
Extreme 223.75
230.65
1 month 207.72
Extreme 207.72
232.34
Current year 171
Extreme 171
258.23
1 year 171
Extreme 171
258.23
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 2020-08-31
Director of Finance/CFO 53 2018-12-31
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 73 1999-06-30
Chairman 73 1982-12-31
Director/Board Member 68 1982-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.39%-0.23%-1.68%-14.74% 160B
-0.43%-3.06%+8.20%+4.04% 215B
+1.18%+0.32%+4.53%+116.04% 204B
-0.20%-4.00%+8.27%+115.94% 145B
+1.92%+1.56%-15.42%-11.65% 56.48B
+0.48%-0.55%+20.49%+19.26% 50.02B
-1.91%-5.22%+3.49%-3.87% 41.18B
+3.56%+6.84%+5.19% - 38.93B
+2.00%+0.28%+6.27%+17.83% 37.39B
+1.19%-0.79%-22.99%-37.74% 34.62B
Average +0.74%-0.37%+1.64%+22.79% 98.21B
Weighted average by Cap. +0.37%-1.09%+3.62%+40.76%
See all sector performances

Financials

2025 *2026 *
Net sales 24.51B 21.07B 19.74B 18.4B 33.98B 2,206B 36.96B 231B 89.14B 1,042B 91.99B 90.03B 3,809B 25.49B 21.91B 20.53B 19.13B 35.34B 2,294B 38.43B 240B 92.7B 1,083B 95.66B 93.62B 3,961B
Net income 3.67B 3.15B 2.95B 2.75B 5.09B 330B 5.53B 34.56B 13.34B 156B 13.77B 13.48B 570B 4.96B 4.26B 3.99B 3.72B 6.88B 446B 7.48B 46.71B 18.04B 211B 18.61B 18.22B 771B
Net Debt 13.13B 11.29B 10.58B 9.86B 18.21B 1,182B 19.81B 124B 47.77B 558B 49.3B 48.25B 2,041B 10.03B 8.62B 8.07B 7.53B 13.9B 902B 15.12B 94.45B 36.47B 426B 37.63B 36.83B 1,558B
More financial data * Estimated data
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
62,000
More about the company
Date Price Change Volume
25-12-05 226.25 $ -0.39% 3,179,645
25-12-04 227.13 $ -0.58% 4,089,322
25-12-03 228.46 $ +0.83% 3,761,065
25-12-02 226.59 $ +1.09% 2,737,086
25-12-01 224.14 $ -1.16% 3,881,251

Delayed Quote Nyse, December 05, 2025 at 04:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
226.25USD
Average target price
255.67USD
Spread / Average Target
+13.00%
Consensus

Quarterly revenue - Rate of surprise